A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 08 Jan 2018
At a glance
- Drugs Hydrogen peroxide (Primary)
- Indications Warts
- Focus Therapeutic Use
- Sponsors Aclaris Therapeutics
- 08 Jan 2018 Results published in the Aclaris Therapeutics media release.
- 08 Jan 2018 Primary endpoint of Physicians Wart Assessment Score has been met, according to an Aclaris Therapeutics media release.
- 31 Oct 2017 Status changed from recruiting to active, no longer recruiting.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History